The Impact of SPC on Advanced Breast Cancer Patients

Breast Cancer Clinical Trial

Official title:

The Influence of Specialist Palliative Care on the Exacerbation of Negative Symptoms, Life Quality and Performance Status of Patients With Advanced Breast Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03612934
• Other study ID #: SPC1
• Status: Completed
• Start date: May 1, 2015
• Est. completion date: May 1, 2018

Study information

• Verified date: July 2018
• Source: Silesian University of Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 144
• Est. completion date: May 1, 2018
• Est. primary completion date: May 1, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 33 Years to 91 Years

Eligibility

Inclusion Criteria:

the patient's conscious consent for examination and the ability to fill in the form by the patient herself.

Exclusion Criteria:

• patients with cognitive disturbances disabling credible answers in the questionnaire, deceased patients or those discharged from the ward before 14 days of hospitalisation.

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms
• Cancer, Breast
• Palliative Care
• Quality of Life

Intervention

Procedure:
• Specialist Palliative Care
In the research, Specialist Palliative Care was provided according to the guidelines established by Mid-Western Health Board in a Report of the National Advisory Committee on Palliative Care as well as according to recommendations of Polish Society of Palliative Medicine and Polish National Healthcare Fund. In order to ensure interdisciplinary and integrated palliative care, a team of specialists was appointed. Team members were engaged in the process of treatment of each patient during the time of the study and applied their specialist skills according to the needs of the patients

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Silesian University of Medicine

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Variation of intensification of patients negative symptoms before and after SPC	intensification of patients negative symptoms was assessed by Edmonton Symptom Assessment System (esas)	14 days
Primary	Variation of performance status of patients before and after SPC	performance status of patients was assessed by ECOG scale (Eastern Cooperative Oncology Group)	14 days
Primary	Variation of quality of life of patients before and after SPC	quality of life of patients of patients was assessed by quality of life uniscale (QoLU)	14 days